Central serous chorioretinopathy: a review of epidemiology and pathophysiology

Central serous chorioretinopathy (CSCR) is a common retinal cause of vision loss. This review surveys the epidemiology, risk factors, clinical presentation, natural history and pathophysiology of CSCR. Studies suggest an annual incidence rate of 10 per 100 000 in men, with CSCR occurring six times more commonly in men compared with women. Most acute CSCR cases resolve spontaneously within 2–3 months. Prognosis is highly dependent on presenting visual acuity; patients with initial visual acuities of 6/6 remain at that level, while patients with initial visual acuities of less than 6/9 recover on average two to three Snellen lines over the next few years. The main risk factors for CSCR are systemic corticosteroid use, type A personality, pregnancy and endogenous Cushing's syndrome. The pathophysiology of CSCR remains obscure, although disorders in both the choroidal circulation and retinal pigment epithelium are implicated.

[1]  T. Rimmer,et al.  Central serous chorioretinopathy following oral tadalafil , 2012, Eye.

[2]  P. Edwards,et al.  Central serous chorioretinopathy in African Americans. , 2003, Journal of the National Medical Association.

[3]  A. Scialdone,et al.  Eight-year follow-up of central serous chorioretinopathy with and without laser treatment , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  Timothy G Murray,et al.  FACTORS ASSOCIATED WITH REDUCED VISUAL ACUITY DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY , 2002, Retina.

[5]  Wolfgang Drexler,et al.  State-of-the-art retinal optical coherence tomography , 2008, Progress in Retinal and Eye Research.

[6]  J. Melby,et al.  Endocrine abnormalities in patients with central serous chorioretinopathy. , 2003, Ophthalmology.

[7]  G. Virgili,et al.  [ICG angiography and retinal pigment epithelial decompensation (CRSC and epitheliopathy)]. , 2001, Journal francais d'ophtalmologie.

[8]  J. Slakter,et al.  Central serous chorioretinopathy in younger and older adults. , 1996, Ophthalmology.

[9]  A. Fawzi,et al.  Central serous chorioretinopathy after solid organ transplantation. , 2006, Ophthalmology.

[10]  Frederick W. Fraunfelder,et al.  Central Serous Chorioretinopathy Associated With Sildenafil , 2008, Retina.

[11]  M F Marmor,et al.  The resorption of subretinal fluid after diffuse damage to the retinal pigment epithelium. , 1983, Investigative ophthalmology & visual science.

[12]  K. Harada,et al.  Six cases of central serous choroidopathy induced by systemic corticosteroid therapy , 1985, Documenta Ophthalmologica.

[13]  A. Tsujikawa,et al.  High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy. , 2010, Ophthalmology.

[14]  M. Spitznas Pathogenesis of central serous retinopathy: A new working hypothesis , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  M. Shanmugam,et al.  Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. , 2004, Ophthalmology.

[16]  Judy E. Kim,et al.  Photodynamic therapy for steroid-associated central serous chorioretinopathy , 2010, British Journal of Ophthalmology.

[17]  D. Bujarborua Long-term follow-up of idiopathic central serous chorioretinopathy without laser. , 2001, Acta ophthalmologica Scandinavica.

[18]  C. Spahn,et al.  Psychosomatic aspects in patients with central serous chorioretinopathy , 2003, The British journal of ophthalmology.

[19]  R. Spaide,et al.  Fundus autofluorescence and central serous chorioretinopathy. , 2005, Ophthalmology.

[20]  Masanori Hangai,et al.  Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. , 2012, Ophthalmology.

[21]  D. Robertson,et al.  The long-term outcome of central serous chorioretinopathy. , 1996, Archives of ophthalmology.

[22]  J D Gass,et al.  Pathogenesis of disciform detachment of the neuroepithelium. , 1967, American journal of ophthalmology.

[23]  C. S. Lee,et al.  CENTRAL SEROUS CHORIORETINOPATHY AFTER RENAL TRANSPLANTATION , 2011, Retina.

[24]  J. Gass,et al.  Idiopathic central serous chorioretinopathy. , 1998, Indian journal of ophthalmology.

[25]  A. Thoelen,et al.  Obstructive sleep apnea in patients with central serous chorioretinopathy , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[26]  C. Pournaras,et al.  Central Serous Chorioretinopathy and Glucocorticoids , 2022 .

[27]  M. Wakakura,et al.  [Central serous chorioretinopathy induced by corticosteroids]. , 1997, Nippon Ganka Gakkai zasshi.

[28]  R. Frank,et al.  Central serous retinopathy and pregnancy. , 1974, American journal of ophthalmology.

[29]  Frcs,et al.  Central Serous Chorioretinopathy , 2012 .

[30]  L. Yannuzzi,et al.  Corticosteroids and central serous chorioretinopathy. , 2002, Ophthalmology.

[31]  O. Chrapek,et al.  [Treatment of central serous chorioretinopathy with beta blockers]. , 2002, Czech and Slovak Ophthalmology.

[32]  F. Bandello,et al.  Nonvisible Subthreshold Micropulse Diode Laser (810 nm) Treatment of Central Serous Chorioretinopathy: A Pilot Study , 2008, European journal of ophthalmology.

[33]  J. Lim,et al.  The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy , 2010, Korean journal of ophthalmology : KJO.

[34]  E. Neoh,et al.  Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant. , 2002, American journal of ophthalmology.

[35]  R. Spaide,et al.  ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY , 2009, Retina.

[36]  J. Pulido,et al.  The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. , 2008, Ophthalmology.

[37]  C. Shields Autofluorescence from the outer retina and subretinal space: hypothesis and review , 2009 .

[38]  Yasuo Tano,et al.  Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[39]  D. Ilstrup,et al.  Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. , 1983, American journal of ophthalmology.

[40]  A. Fawzi,et al.  Central serous chorioretinopathy after bone marrow transplantation. , 2001, American journal of ophthalmology.

[41]  A. Koh,et al.  Angiographic characteristics of acute central serous chorioretinopathy in an Asian population. , 2006, Annals of the Academy of Medicine, Singapore.

[42]  E. Cunningham,et al.  Central serous chorioretinopathy in patients with systemic lupus erythematosus. , 1996, Ophthalmology.

[43]  G. Dutton,et al.  Central Visual Function in Patients With Resolved Central Serous Retinopathy: A Long-Term Followup Study , 1990 .

[44]  A. Bird,et al.  Abnormalities of fundus autofluorescence in central serous retinopathy. , 2002, American journal of ophthalmology-glaucoma.

[45]  A. Stigliano,et al.  Central Serous Chorioretinopathy as a Presenting Symptom of Endogenous Cushing Syndrome: A Case Report , 2011, European journal of ophthalmology.

[46]  M. Mäntyjärvi,et al.  Contrast sensitivity in patients recovered from central serous chorioretinopathy , 2004, International Ophthalmology.

[47]  M. Iovene,et al.  Central Serous Chorioretinopathy and Helicobacter Pylori , 2006, European journal of ophthalmology.

[48]  Guang-Hui Wang,et al.  Value of Three-Dimensional Optical Coherence Tomography and Fundus Photochromy in Correlating the Fluorescein Leaking Sites of Acute Central Serous Chorioretinopathy , 2011, Medical Principles and Practice.

[49]  M. Gao,et al.  [Morphologic changes in acute central serous chorioretinopathy evaluated by spectral domain optical coherence tomography]. , 2011, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[50]  L. Yannuzzi TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY , 2012, Retina.

[51]  S. W. Kang,et al.  Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy , 2011, Eye.

[52]  R. Ebner,et al.  True, true and related? , 2001, Survey of ophthalmology.

[53]  M. Goff,et al.  THE NATURAL HISTORY OF PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY , 2007, Retina.

[54]  L. Schmetterer,et al.  Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy. , 2005, Investigative ophthalmology & visual science.

[55]  K. Freund,et al.  THE EFFECTS OF SILDENAFIL CITRATE ON CHOROIDAL THICKNESS AS DETERMINED BY ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY , 2011, Retina.

[56]  F. Boscia,et al.  Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. , 2010, American journal of ophthalmology.

[57]  J. Lim,et al.  The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[58]  Ritu Gadia,et al.  Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. , 2006, Investigative ophthalmology & visual science.

[59]  R. Spaide AUTOFLUORESCENCE FROM THE OUTER RETINA AND SUBRETINAL SPACE: Hypothesis and Review , 2008, Retina.

[60]  F C Piccolino,et al.  CENTRAL SEROUS CHORIORETINOPATHY AND INDOCYANINE GREEN ANGIOGRAPHY , 1994, Retina.

[61]  P. Venkatesh,et al.  Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: A pilot, randomized controlled trial [ISRCTN84128484] , 2004, BMC ophthalmology.

[62]  C. Giusti Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. , 2005, Medical hypotheses.

[63]  C. Margo,et al.  CENTRAL SEROUS CHORIORETINOPATHY AND PHOSPHODIESTERASE-5 INHIBITORS: A Case–Control Postmarketing Surveillance Study , 2010, Retina.

[64]  C. Eandi,et al.  Photodynamic Therapy for Chronic Central Serous Chorioretinopathy , 2003, Retina.

[65]  J. Slakter,et al.  INDOCYANINE GREEN ANGIOGRAPHY‐GUIDED PHOTODYNAMIC THERAPY FOR TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A Pilot Study , 2003, Retina.

[66]  Joo Yong Lee,et al.  Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy , 2011, Acta ophthalmologica.

[67]  E. Chew,et al.  FINASTERIDE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2011, Retina.

[68]  Miki Sawa,et al.  Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. , 2010, American journal of ophthalmology.

[69]  J. Flammer,et al.  The potential role of testosterone in central serous chorioretinopathy , 2006, British Journal of Ophthalmology.

[70]  G. Ravera,et al.  RISK FACTORS FOR POSTERIOR CYSTOID RETINAL DEGENERATION IN CENTRAL SEROUS CHORIORETINOPATHY , 2008, Retina.

[71]  N. Eter,et al.  Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study , 2009, Acta ophthalmologica.

[72]  A. Lotery,et al.  Central serous chorioretinopathy: an update on pathogenesis and treatment , 2010, Eye.

[73]  T. Lim,et al.  Central serous retinopathy complicating systemic lupus erythematosus: a case series , 2000, Clinical & experimental ophthalmology.

[74]  Sun Jinghua,et al.  Effect of catecholamine on central serous chorioretinopathy , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[75]  N. Kerr,et al.  Phosphodiesterase inhibitors and the eye , 2009, Clinical & experimental ophthalmology.

[76]  J. Ruiz-Moreno,et al.  Photodynamic therapy for chronic central serous chorioretinopathy , 2009, Acta ophthalmologica.

[77]  L. Yannuzzi,et al.  Peripheral Retinal Detachments and Retinal Pigment Epithelial Atrophic Tracts Secondary to Central Serous Pigment Epitheliopathy , 2012, Ophthalmology.

[78]  S. Fine,et al.  Long-term follow-up of central serous chorioretinopathy. , 1984, The British journal of ophthalmology.

[79]  A. Tatham,et al.  The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[80]  C. Schmid,et al.  Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. , 2000, Retina.

[81]  S. Fine,et al.  Central serous chorioretinopathy and pregnancy. , 1993, Archives of ophthalmology.

[82]  J. Castro-Correia,et al.  Long-term follow-up of central serous retinopathy in 150 patients , 2004, Documenta Ophthalmologica.

[83]  L. Jampol,et al.  ORAL MIFEPRISTONE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2011, Retina.

[84]  J. Slakter,et al.  Systemic findings associated with central serous chorioretinopathy. , 1999, American journal of ophthalmology.

[85]  M. Friedman,et al.  Elevated Daytime Urinary Excretion of Testosterone Glucuronide in Men with the Type A Behavior Pattern , 1984, Psychosomatic medicine.

[86]  D. Gagnon,et al.  Risk factors for central serous chorioretinopathy: a case-control study. , 2004, Ophthalmology.

[87]  S. Hayasaka,et al.  Fluorescein-angiographic patterns in patients with central serous chorioretinopathy at the initial visit. , 1992, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[88]  J. Jonas,et al.  Intravitreal triamcinolone acetonide and central serous chorioretinopathy , 2005, British Journal of Ophthalmology.

[89]  A. Javadzadeh,et al.  The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy , 2011, Molecular vision.

[90]  J. Oosterhuis,et al.  Familial Chronic Central Serous Chorioretinopathy , 2001, Ophthalmologica.

[91]  T. Lai,et al.  Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. , 2008, Ophthalmology.

[92]  J. Gass Central serous chorioretinopathy and white subretinal exudation during pregnancy. , 1991, Archives of ophthalmology.

[93]  H. Bahçecioğlu,et al.  Intravitreal Bevacizumab in Treatment of Idiopathic Persistent Central Serous Chorioretinopathy: A Prospective, Controlled Clinical Study , 2010, Current eye research.

[94]  San-Ni Chen,et al.  Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. , 2008, Ophthalmology.

[95]  L. Laatikainen,et al.  Long-term follow-up Study of Nonsenile Detachment of the Retinal Pigment Epithelium , 1991, European journal of ophthalmology.

[96]  S. Harino,et al.  Two cases of central serous chorioretinopathy treated with photocoagulation after bone marrow transplantation. , 2002, Retina.

[97]  D. Talwar,et al.  Endogenous cortisol profile in patients with central serous chorioretinopathy , 1997, The British journal of ophthalmology.

[98]  D. Boyer,et al.  Chronic central serous chorioretinopathy: photodynamic therapy. , 2004, American journal of ophthalmology.

[99]  K. Imbierowicz,et al.  [Central serous chorioretinopathy and psychological stress]. , 2000, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[100]  S. Kang,et al.  Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy , 2010, British Journal of Ophthalmology.

[101]  R B Rosen,et al.  Evaluation of central serous retinopathy with en face optical coherence tomography , 2005, British Journal of Ophthalmology.

[102]  G. Ravera,et al.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. , 2005, American journal of ophthalmology.

[103]  Atul K. Jain,et al.  Bilateral central serous chorioretinopathy resolving rapidly with treatment for obstructive sleep apnea , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[104]  F. Geiser,et al.  Chorioretinopathia centralis serosa und psychische Belastung , 2000, Der Ophthalmologe.

[105]  J. Flammer,et al.  Choroidal capillary and venous congestion in central serous chorioretinopathy. , 1996, American journal of ophthalmology.

[106]  L. Ficker,et al.  Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. , 1988, The British journal of ophthalmology.

[107]  J. Fabianová,et al.  [Central serous chorioretinopathy--treatment with beta blockers]. , 1998, Czech and Slovak Ophthalmology.

[108]  Richard Hackel,et al.  DETECTION OF RETINAL METABOLIC STRESS RESULTING FROM CENTRAL SEROUS RETINOPATHY , 2009, Retina.

[109]  Michael D. Ober,et al.  ACUTE CENTRAL SEROUS CHORIORETINOPATHY AND FUNDUS AUTOFLUORESCENCE , 2005, Retina.

[110]  Soon-Sun Kwon,et al.  COMPARISON OF CHOROIDAL THICKNESS AMONG PATIENTS WITH HEALTHY EYES, EARLY AGE-RELATED MACULOPATHY, NEOVASCULAR AGE-RELATED MACULAR DEGENERATION, CENTRAL SEROUS CHORIORETINOPATHY, AND POLYPOIDAL CHOROIDAL VASCULOPATHY , 2011, Retina.

[111]  A. Safran,et al.  Should Central Serous Chorioretinopathy Be Added to the List of Ocular Side Effects of Phosphodiesterase 5 Inhibitors? , 2011, Ophthalmologica.

[112]  G. Gelber,et al.  Loss of vision due to central serous chorioretinopathy following psychological stress. , 1987, The American journal of psychiatry.

[113]  A. Ho,et al.  Digital indocyanine green videoangiography of central serous chorioretinopathy. , 1994, Archives of ophthalmology.

[114]  M. Kaiser-Kupfer,et al.  Central serous chorioretinopathy in endogenous hypercortisolism. , 1993, Archives of ophthalmology.

[115]  Kazuhiko Hayashi,et al.  Indocyanine green angiography of central serous chorioretinopathy , 1986, International Ophthalmology.

[116]  D. Park,et al.  Central Serous Chorioretinopathy in Two Families , 1998, European journal of ophthalmology.

[117]  Y. Tano,et al.  Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography. , 2008, Ophthalmology.

[118]  R. Chervin,et al.  Central serous chorioretinopathy and risk for obstructive sleep apnea , 2007, Sleep and Breathing.

[119]  J. Gomolin Choroidal neovascularization and central serous chorioretinopathy. , 1989, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[120]  T. Gardner,et al.  Central serous chorioretinopathy in women. , 1996, Ophthalmology.

[121]  C. Spahn,et al.  [Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy]. , 2004, PPmP. Psychotherapie, Psychosomatik, medizinische Psychologie.

[122]  P Leaver,et al.  Argon laser photocoagulation in the treatment of central serous retinopathy. , 1979, The British journal of ophthalmology.

[123]  N. Evans,et al.  Central serous chorioretinopathy associated with testosterone therapy , 2006, Eye.

[124]  I. Toda,et al.  Identification of androgen receptor protein and 5α-reductase mRNA in human ocular tissues , 2000, The British journal of ophthalmology.

[125]  E Niskanen,et al.  MARROW TRANSPLANTATION , 1977, Duodecim; laaketieteellinen aikakauskirja.

[126]  G. Holder,et al.  Visual loss from central serous retinopathy in systemic lupus erythematosus. , 1993, The British journal of ophthalmology.

[127]  O. Sharma,et al.  Sarcoidosis and central serous retinopathy: a dangerous combination. , 1998, Sarcoidosis Vasculities and Diffuse Lung Diseases.

[128]  James G. Fujimoto,et al.  CHOROIDAL IMAGING USING SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY , 2012, Retina.

[129]  J. Lim,et al.  AQUEOUS HUMOR AND PLASMA LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY , 2010, Retina.

[130]  F. Piccolino,et al.  Posterior Cystoid Retinal Degeneration in Central Serous Chorioretinopathy , 2008, Retina.